#1 Clinical Trials Search in Europe

Sumatriptan Succinate

Sumatriptan Succinate, a medication used to treat migraines and cluster headaches, has been the subject of several clinical trials. These studies aim to evaluate its effectiveness, safety, and various delivery methods. The trials compare different formulations of Sumatriptan Succinate, including oral tablets, injections, nasal sprays, and innovative delivery systems like transdermal patches. Researchers are exploring how these different forms of the medication affect its absorption, distribution, and overall effectiveness in treating migraine symptoms.

Table of Contents

What is Sumatriptan Succinate?

Sumatriptan Succinate is a medication primarily used for the treatment of migraine headaches. It belongs to a class of drugs known as triptans, which are specifically designed to alleviate migraine symptoms. Sumatriptan is also known by its brand name Imitrex[1].

What Conditions Does Sumatriptan Treat?

Sumatriptan is primarily used to treat:

  • Migraine headaches: This includes migraines with or without aura. An aura is a sensory disturbance that some people experience before a migraine attack, such as seeing flashing lights or experiencing numbness[2].
  • Cluster headaches: These are extremely painful headaches that occur in cyclical patterns or clusters[3].

How is Sumatriptan Administered?

Sumatriptan can be administered in several ways:

  • Oral tablets: Available in various strengths, including 100mg tablets[4].
  • Subcutaneous injection: This is an injection given just under the skin, often using a device called the IMITREX STATdose System. It’s available in 4mg and 6mg doses[5].
  • Nasal spray: This formulation is sprayed into the nostril[1].
  • Transdermal patch: This is a newer method of administration where the medication is delivered through the skin. It’s still under research and development[6].

How Does Sumatriptan Work?

Sumatriptan works by:

  • Narrowing blood vessels in the brain, which can become dilated during a migraine attack.
  • Blocking the release of certain chemicals in the brain that cause pain and other migraine symptoms.
  • Reducing inflammation in the brain that contributes to migraine pain[2].

Effectiveness of Sumatriptan

Clinical trials have shown that Sumatriptan is effective in treating migraine headaches. Some key findings include:

  • Many patients experience headache relief within 2 hours of taking the medication.
  • Sumatriptan can also help alleviate other migraine symptoms such as nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound)[2].
  • The effectiveness can vary depending on the method of administration and the individual patient.

Potential Side Effects

Like all medications, Sumatriptan can cause side effects. Common side effects may include:

  • Tingling or warm sensations
  • Dizziness
  • Fatigue
  • Chest discomfort
  • Injection site reactions (for the injectable form)
  • Nasal discomfort (for the nasal spray form)[5]

It’s important to discuss potential side effects with your healthcare provider before starting treatment.

Ongoing Research and Development

Researchers continue to study Sumatriptan to improve its effectiveness and delivery methods. Some areas of ongoing research include:

  • Combination therapies: For example, a combination of Sumatriptan and Naproxen Sodium (known as Trexima) is being studied for potential improved efficacy[5].
  • New delivery methods: Such as the Sofusa system, which is a transdermal delivery system designed to administer Sumatriptan through the skin[6].
  • Improved formulations: Researchers are working on developing formulations that may provide faster relief or have fewer side effects[7].
Aspect Details
Study Types Pharmacokinetic studies, bioequivalence studies, safety and efficacy trials
Formulations Studied Oral tablets, subcutaneous injections, nasal sprays, transdermal patches, iontophoretic systems
Key Measures Cmax (maximum concentration), AUC (area under the curve), Tmax (time to maximum concentration)
Comparison Products Imitrex (brand name for sumatriptan), TREXIMA (combination of sumatriptan and naproxen)
Novel Delivery Systems Sofusa system, NP101 iontophoretic transdermal patch
Study Designs Crossover studies, open-label trials, randomized controlled trials
Patient Populations Healthy volunteers, migraine patients, cluster headache patients
Safety Assessments Adverse events, vital signs, ECGs, clinical laboratory tests

FAQ

  • What is Sumatriptan Succinate? Sumatriptan Succinate is a medication used to treat migraines and cluster headaches. It belongs to a class of drugs called triptans, which work by narrowing blood vessels in the brain and blocking pain signals.
  • What forms of Sumatriptan Succinate are being studied? Clinical trials are studying various forms of Sumatriptan Succinate, including oral tablets, subcutaneous injections, nasal sprays, and innovative delivery systems like transdermal patches and iontophoretic systems.
  • What is the purpose of comparing different formulations of Sumatriptan Succinate? Researchers compare different formulations to evaluate how they affect the medication's absorption, distribution, and effectiveness. This helps determine which forms might provide better relief for migraine symptoms or have fewer side effects.
  • What is a pharmacokinetic (PK) study? A pharmacokinetic study examines how the body processes a drug. It looks at factors like how quickly the drug is absorbed, how it's distributed in the body, and how long it takes to be eliminated. This information helps researchers understand the best ways to administer the medication.
  • Are there any new delivery methods being tested for Sumatriptan Succinate? Yes, some trials are testing new delivery methods such as the Sofusa system, which is a transdermal delivery system, and the NP101 iontophoretic transdermal patch. These methods aim to provide alternative ways of administering the medication that might be more effective or convenient for patients.

Ongoing Clinical Trials on Sumatriptan Succinate

  • Study on the Effects of Cilostazol on Headaches in Men and Women with Migraine Without Aura

    Recruiting

    1 1
    Investigated drugs:
    Denmark

  • Study on Headache Effects of Sildenafil and Placebo in Men and Women with Episodic Migraine Without Aura

    Not recruiting

    1 1
    Investigated drugs:
    Denmark

Glossary

  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and elimination.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Cmax: The maximum concentration of a drug observed in the blood plasma after administration.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used to assess bioavailability and equivalence between different formulations.
  • Iontophoretic Transdermal System: A method of delivering medication through the skin using a mild electrical current to help the drug penetrate more effectively.
  • Crossover Study: A type of clinical trial where participants receive different treatments in a specific order, allowing each person to serve as their own control.
  • Subcutaneous Injection: An injection given into the fatty tissue just beneath the skin.
  • Bioequivalence: The property of two drug products having the same biological effect in the body.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood plasma after administration.
  • TREXIMA: A combination medication containing sumatriptan succinate and naproxen sodium, used for migraine treatment.

References

  1. https://clinicaltrials.gov/study/NCT00546650
  2. https://clinicaltrials.gov/study/NCT00920686
  3. https://clinicaltrials.gov/study/NCT00356603
  4. https://clinicaltrials.gov/study/NCT00847405
  5. https://clinicaltrials.gov/study/NCT00875784
  6. https://clinicaltrials.gov/study/NCT03229798
  7. https://clinicaltrials.gov/study/NCT01381796